Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Financials
Key financial figures for Madrigal Pharmaceuticals, Inc. Common Stock (Q2 2026).
- Revenue
- $364M
- Net Income
- -$58M
- EPS
- $-1.99
- Total Assets
- $1.2B
- Operating Cash Flow
- $23M
Full income statement, balance sheet, and cash flow for Madrigal Pharmaceuticals, Inc. Common Stock on SentiSense.